CD59 protects against lesion formation in LDL receptor deficient mice: Evidence for complement activation in atherogenesis

被引:0
|
作者
Yun, S.
Leung, V.
Botto, M.
Haskard, D. O.
Boyle, J. J.
机构
[1] Univ London Imperial Coll Sci Technol & Med, BHF Cardiovasc Med Unit, London W12 0NN, England
[2] Univ London Imperial Coll Sci Technol & Med, Rheumatol Unit, London W12 0NN, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
029
引用
收藏
页数:2
相关论文
共 45 条
  • [21] Monoclonal antibody against murine macrophage colony-stimulating factor receptor inhibits atherogenesis in LDL receptor-deficient mice
    Rajavashisth, TB
    Shah, PK
    Qiao, JH
    Tripathi, S
    CIRCULATION, 1998, 98 (17) : 327 - 327
  • [22] Human CD46 but not CD59 intransgenic mice protects against hyperacute rejection evoked by ex vivo perfusion with human serum
    Marquet, RL
    vanStijn, I
    vandenTol, PM
    Bonthuis, F
    Yannoutsos, N
    Ijzermans, JNM
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 931 - 932
  • [23] CD44-deficiency on hematopoietic cells limits T-cell number but does not protect against atherogenesis in LDL receptor-deficient mice
    Sjoberg, Sara
    Eriksson, Einar E.
    Tivesten, Asa
    Carlsson, Annelie
    Klasson, Anna
    Levin, Max
    Boren, Jan
    Krettek, Alexandra
    ATHEROSCLEROSIS, 2009, 206 (02) : 369 - 374
  • [24] Overexpression of Human CD55 and CD59 or Treatment with Human CD55 Protects against Renal Ischemia-Reperfusion Injury in Mice
    Bongoni, Anjan K.
    Lu, Bo
    Salvaris, Evelyn J.
    Roberts, Veena
    Fang, Doreen
    Mcrae, Jennifer L.
    Fisicaro, Nella
    Dwyer, Karen M.
    Cowan, Peter J.
    JOURNAL OF IMMUNOLOGY, 2017, 198 (12): : 4837 - 4845
  • [25] Macrophage expression of PPAR-alpha inhibits atherosclerotic lesion formation in LDL-receptor deficient mice
    Babaev, VR
    Major, AS
    Zhu, TL
    Hiroyuki, I
    Dove, DE
    Fazio, S
    Linton, MF
    Semenkovich, CF
    CIRCULATION, 2001, 104 (17) : 45 - 46
  • [26] Vaccination against CD99 inhibits atherogenesis in low-density lipoprotein receptor-deficient mice
    van Wanrooij, Eva J. A.
    de Vos, Paula
    Bixel, M. Gabriele
    Vestweber, Dietmar
    van Berkel, Theo J. C.
    Kuiper, Johan
    CARDIOVASCULAR RESEARCH, 2008, 78 (03) : 590 - 596
  • [27] 12/15 Lipoxygenase gene deletion attenuates atherogenesis in LDL-Receptor deficient mice: Evidence for the involvement of macrophages in-vivo
    Jacob, G
    Afek, A
    Shaish, A
    Levkovitz, H
    Bloom, N
    Funk, C
    Sigal, E
    CIRCULATION, 2000, 102 (18) : 239 - 240
  • [28] Influence of complement C1Q deficiency on early lesion formation in LDL receptor knock-out mice
    Bhatia, VK
    Boyle, JJ
    Roberts, CE
    Grimsditch, DC
    Sadler, Y
    Benson, G
    Botto, MB
    Haskard, DO
    ATHEROSCLEROSIS, 2003, 170 (01) : S3 - S3
  • [29] Effects of Alnus japonica extracts on inflammatory signal dependent-atherosclerotic lesion formation in LDL receptor-deficient mice
    Han, Jong-Min
    An, Sojin
    Kim, Min-Jung
    Jin, Yue-Yan
    Baek, Seung-Wha
    Park, Ji-Seon
    Lee, Woo Song
    Jeong, Tae-Sook
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) : E55 - E55
  • [30] Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
    Febbraio, M
    Podrez, EA
    Smith, JD
    Hajjar, DP
    Hazen, SL
    Hoff, HF
    Sharma, K
    Silverstein, RL
    JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (08): : 1049 - 1056